Truxima: “Now Approved” Page Dec 4, 2018Dec 4, 2018 Brand: Truxima (rituximab-abbs), Injection Parent Company: Teva Drug Type: Boxed Warning Drug Category: Oncology Campaign: now-approved Targeting: HCPs, Patients Patient Website: https://www.truxima.com/ HCP Website: Desktop Page Mobile Page